4.6 Article

Highly Active Antiretroviral Therapy and Increased Use of Contraceptives Among HIV-Positive Women During Expanding Access to Antiretroviral Therapy in Mbarara, Uganda

Journal

AMERICAN JOURNAL OF PUBLIC HEALTH
Volume 99, Issue 2, Pages 340-347

Publisher

AMER PUBLIC HEALTH ASSOC INC
DOI: 10.2105/AJPH.2007.129528

Keywords

-

Funding

  1. National Institutes of Health [MH54907]
  2. University of California, San Francisco
  3. Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 AI27763]
  4. National Institute on Alcohol Abuse and Alcoholism [K-24 015287-01]
  5. Canadian Institutes of Health Research
  6. Michael Smith Foundation for Health Research

Ask authors/readers for more resources

Objectives. We investigated whether the prevalence of contraceptive use among women who are HIV positive varied according to use of highly active antiretroviral therapy (HAART) in Mbarara, Uganda. Methods. We used data from a cross-sectional survey of 484 women who were HIV positive (18-50 years) and were attending Mbarara University's HIV clinic, 45% of whom were receiving HAART. Multivariate logistic regression was used to investigate the association between HAART use and contraceptive use. Data were collected between November 2005 and June 2006. Results. Overall, 45% of the women were sexually active in the previous 3 months. Of these, 85% reported using contraceptive methods, with 84% reporting use of barrier contraceptive methods. Women receiving HAART were more than twice as likely to use contraceptive methods (adjusted odds ratio [AOR]=2.64; 95% confidence interval [CI] = 1.07, 6.49) and more than 3 times as likely to use barrier contraceptive methods (AOR=3.62; 95% CI=11.54, 8.55) than were women not receiving HAART. Conclusions. Our findings support the need for increased attention to better integration of reproductive health and HIV and AIDS services for women who are HIV positive. (Am J Public Health. 2009;99:340-347. doi:10.2105/AJPH.2007.129528)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available